Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (212) 212
Publication (26) 26
Book / eBook (11) 11
Patent (5) 5
Conference Proceeding (4) 4
Book Review (1) 1
Dissertation (1) 1
Magazine Article (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (103) 103
humans (94) 94
female (49) 49
oncology (39) 39
male (38) 38
cancer (37) 37
clinical neurology (37) 37
glioblastoma (35) 35
tumors (35) 35
adult (34) 34
middle aged (33) 33
animals (29) 29
neurosciences (28) 28
aged (27) 27
analysis (26) 26
brain neoplasms - pathology (22) 22
gliomas (22) 22
immunohistochemistry (22) 22
pathology (22) 22
angiogenesis (21) 21
brain neoplasms - metabolism (21) 21
mice (21) 21
brain tumors (20) 20
glioma (20) 20
hypoxia (20) 20
research (19) 19
aged, 80 and over (18) 18
patients (18) 18
article (17) 17
cell line, tumor (17) 17
mutation (17) 17
expression (16) 16
health aspects (16) 16
medicine & public health (16) 16
survival (16) 16
young adult (16) 16
adolescent (14) 14
apoptosis (14) 14
bevacizumab (14) 14
brain cancer (14) 14
inhibition (14) 14
medical research (14) 14
multidisciplinary sciences (14) 14
prognosis (14) 14
brain (13) 13
cancer therapies (13) 13
medicine (13) 13
research article (13) 13
child (12) 12
clinical trials (12) 12
magnetic resonance imaging (12) 12
methylation (12) 12
invasion (11) 11
metastasis (11) 11
proteins (11) 11
gene expression (10) 10
genetic aspects (10) 10
glioblastoma - pathology (10) 10
medical prognosis (10) 10
metabolism (10) 10
neurology (10) 10
studies (10) 10
biochemistry & molecular biology (9) 9
brain neoplasms - mortality (9) 9
care and treatment (9) 9
chemotherapy (9) 9
cohort studies (9) 9
deoxyribonucleic acid--dna (9) 9
development and progression (9) 9
diagnosis (9) 9
gene expression regulation, neoplastic (9) 9
glioblastoma - metabolism (9) 9
glioblastoma multiforme (9) 9
glioma - pathology (9) 9
growth (9) 9
mice, inbred c57bl (9) 9
rodents (9) 9
science (9) 9
signal transduction (9) 9
survival analysis (9) 9
biomarkers, tumor - metabolism (8) 8
brain - pathology (8) 8
brain neoplasms - genetics (8) 8
cells (8) 8
central-nervous-system (8) 8
child, preschool (8) 8
classification (8) 8
data processing (8) 8
dna methylation (8) 8
up-regulation (8) 8
activation (7) 7
biopsy (7) 7
brain - metabolism (7) 7
brain research (7) 7
cell biology (7) 7
cell proliferation (7) 7
chemistry (7) 7
disease models, animal (7) 7
endothelial cells (7) 7
genetic predisposition to disease (7) 7
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (5) 5
UTL at Downsview - May be requested (4) 4
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Faculty of Information - Stacks (1) 1
Gerstein Science - Stacks (1) 1
OISE - Stacks (1) 1
Robarts - Reference (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
St. Michael's College (John M. Kelly) - 3rd Floor (1) 1
Trinity College (John W Graham) - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text IGF1R Is a Potential New Therapeutic Target for HGNET-BCOR Brain Tumor Patients
by Vewinger, N and Huprich, S and Seidmann, L and Russo, A and Alt, F and Bender, H and Sommer, C and Samuel, D and Lehmann, N and Backes, N and Roth, L and Harter, PN and Filipski, K and Faber, J and Paret, C
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, ISSN 1422-0067, 06/2019, Volume 20, Issue 12, p. 3027
(1) Background: The high-grade neuroepithelial tumor of the central nervous system with BCOR alteration (HGNET-BCOR) is a highly malignant tumor. Preclinical... 
ACTIVATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | IGF2 | CLASSIFICATION | ceritinib | CHEMISTRY, MULTIDISCIPLINARY | HGNET-BCOR | IGF1R | ANAPLASTIC LYMPHOMA KINASE | vinblastine | RECURRENT | CENTRAL-NERVOUS-SYSTEM | INHIBITOR | IGF-1R | FACTOR-I RECEPTOR | MEDULLOBLASTOMA | Cell proliferation | Slopes | Brain | Pediatrics | Actinomycin | Phosphorylation | Copy number | Downstream effects | Brain tumors | Brain cancer | Central nervous system | AKT protein | Insulin-like growth factors | Metastasis | Neuroblastoma | Cannibalism | Drug development | Kinases | Cancer therapies | Proteins | Consortia | DNA methylation | Insulin-like growth factor II | Growth factors | Deoxyribonucleic acid--DNA | Medical research | Vinblastine | Therapeutic applications | Electron microscopy | Vincristine | Patients | Insulin | Brain research | Molecular modelling | Microscopy | Lymphomas | Methylation | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Bevacizumab for patients with recurrent multifocal glioblastomas
by Burger, Michael C and Breuer, Stella and Cieplik, Hans C and Harter, Patrick N and Franz, Kea and Bähr, Oliver and Steinbach, Joachim P
International Journal of Molecular Sciences, ISSN 1661-6596, 11/2017, Volume 18, Issue 11, p. 2469
In patients with glioblastoma, antiangiogenic therapy with bevacizumab (BEV) has been shown to improve progression-free survival (PFS), but not overall... 
Multifocal | Anti-angiogenic therapy | Infiltration | Glioblastoma | Invasive growth | Bevacizumab | SURVIVAL | anti-angiogenic therapy | NEWLY-DIAGNOSED GLIOBLASTOMA | LOMUSTINE | BIOCHEMISTRY & MOLECULAR BIOLOGY | CHEMISTRY, MULTIDISCIPLINARY | infiltration | TEMOZOLOMIDE | invasive growth | MALIGNANT GLIOMA | TRIAL | INVASION | glioblastoma | THERAPY | multifocal | bevacizumab | RADIOTHERAPY | PROGRESSION | Therapy | Nuclear magnetic resonance--NMR | Brain cancer | Patients | Survival | Cancer therapies | Irinotecan | Magnetic resonance imaging | Antiangiogenics | Medical prognosis | Lesions
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Influence of pregnancy on glioma patients
by Forster, Marie-Therese and Baumgarten, Peter and Gessler, Florian and Maurer, Gabriele and Senft, Christian and Hattingen, Elke and Seifert, Volker and Harter, Patrick N and Franz, Kea
Acta Neurochirurgica, ISSN 0001-6268, 2019, Volume 161, Issue 3, pp. 535 - 543
BackgroundData about the influence of pregnancy on progression-free survival and overall survival of glioma patients are sparse and controversial. We aimed at... 
Brain tumor | Pregnancy | Glioma | Matched-pairs analysis | SURVIVAL | SURGERY | SERIES | RESECTION | RESPONSE ASSESSMENT | TUMOR | RISK | EXOGENOUS HORMONE USE | SUPRATENTORIAL | CLINICAL NEUROLOGY | LOW-GRADE GLIOMA | REPRODUCTIVE FACTORS | Neonates | Brain cancer | Birth | Survival | Patients | Oligodendroglioma | Spiders | Surgery | Children | Astrocytoma | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Tumorigenic and antiproliferative properties of the TALE-transcription factors MEIS2D and MEIS2A in neuroblastoma
by GroΒ, Anja and Schulz, Catrine and Kolb, Jasmine and Koster, Jan and Wehner, Sibylle and Czaplinski, Sebastian and Khilan, Abdulghani and Rohrer, Hermann and Harter, Patrick N and Klingebiel, Thomas and Langer, Julian D and Geerts, Dirk and Schulte, Dorothea
Cancer Research, ISSN 0008-5472, 04/2018, Volume 78, Issue 8, pp. 1935 - 1947
Neuroblastoma is one of only a few human cancers that can spontaneously regress even after extensive dissemination, a poorly understood phenomenon that occurs... 
ARREST | CELLS | COMPLEX | RETINOIC ACID | ONCOLOGY | ROLES | MECHANISMS | SENESCENCE | DIFFERENTIATION | FATE | PROGRAM | Cell proliferation | Alternative splicing | Pediatrics | Transcription factors | Phenotypes | Therapeutic applications | Feedback loops | Malignancy | Neuroblastoma | Neuroblastoma cells | Homeobox | Signaling | Negative feedback | Isoforms | Retinoic acid | Tumors | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Distribution and prognostic impact of microglia/macrophage subpopulations in gliomas
by Zeiner, Pia S and Preusse, Corinna and Golebiewska, Anna and Zinke, Jenny and Iriondo, Ane and Muller, Arnaud and Kaoma, Tony and Filipski, Katharina and Müller‐Eschner, Monika and Bernatz, Simon and Blank, Anna‐Eva and Baumgarten, Peter and Ilina, Elena and Grote, Anne and Hansmann, Martin L and Verhoff, Marcel A and Franz, Kea and Feuerhake, Friedrich and Steinbach, Joachim P and Wischhusen, Jörg and Stenzel, Werner and Niclou, Simone P and Harter, Patrick N and Mittelbronn, Michel
Brain Pathology, ISSN 1015-6305, 07/2019, Volume 29, Issue 4, pp. 513 - 529
While the central nervous system is considered an immunoprivileged site and brain tumors display immunosuppressive features, both innate and adaptive immune... 
glioma‐associated microglia and macrophages | immune polarization | glioma | tumor microenvironment | SURVIVAL | SYSTEM | CELLS | PATHOLOGY | glioma-associated microglia and macrophages | NEUROSCIENCES | PRIMARY INTRACRANIAL TUMORS | CLINICAL NEUROLOGY | INFILTRATION | BREAST-CANCER | HUMAN GLIOBLASTOMAS | GENE-EXPRESSION | TUMOR-ASSOCIATED MACROPHAGES | POLARIZATION | RNA | Gliomas | Analysis | Brain tumors | Slopes | Brain | Immunocytochemistry | Brain cancer | Carbon tetrachloride | Glioblastoma | Central nervous system | Macrophages | Phagocytes | Interleukin 1 | Impact resistance | Immune system | Subpopulations | CD11b antigen | Immune response | Markers | Inflammation | Gene expression | Survival | Patients | Microglia | CD163 antigen | Glioma | Interleukin 10 | Monocyte chemoattractant protein 1 | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Dexamethasone-induced leukocytosis is associated with poor survival in newly diagnosed glioblastoma
by Dubinski, Daniel and Won, Sae-Yeon and Gessler, Florian and Quick-Weller, Johanna and Behmanesh, Bedjan and Bernatz, Simon and Forster, Marie-Therese and Franz, Kea and Plate, Karl-Heinz and Seifert, Volker and Harter, Patrick N and Senft, Christian
Journal of Neuro-Oncology, ISSN 0167-594X, 05/2018, Volume 137, Issue 3, pp. 503 - 510
Despite its well-characterized side effects, dexamethasone is widely used in the pre-, peri- and postoperative neurosurgical setting due to its effective... 
Tumor-infiltration | Leukocytosis | Cerebral edema | Survival | Glioblastoma | GLUCOCORTICOIDS | BEVACIZUMAB | NEUTROPHILS | CLINICAL NEUROLOGY | BRAIN-TUMORS | INFILTRATION | ONCOLOGY | EDEMA | HUMAN GLIOMAS | Prognosis | Humans | Middle Aged | Brain Neoplasms - pathology | Dexamethasone - adverse effects | Male | Leukocytosis - mortality | Brain Neoplasms - surgery | Incidence | Antineoplastic Agents, Hormonal - adverse effects | Antineoplastic Agents, Hormonal - therapeutic use | Female | Retrospective Studies | Brain Neoplasms - mortality | Leukocytosis - pathology | Risk Factors | Leukocytosis - diagnosis | Leukocytosis - etiology | Brain Neoplasms - drug therapy | Glioblastoma - surgery | Brain - drug effects | Dexamethasone - therapeutic use | Glioblastoma - pathology | Survival Analysis | Brain - pathology | Brain - surgery | Glioblastoma - drug therapy | Glioblastoma - mortality | Dexamethasone | Analysis | Central nervous system depressants | Blood cell count | Glioblastoma multiforme | Risk factors | Steroids | Edema | CD3 antigen | Neurosurgery | Leukocytes (granulocytic) | Tumors | Metastases
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Targeting APLN/APLNR Improves Antiangiogenic Efficiency and Blunts Proinvasive Side Effects of VEGFA/VEGFR2 Blockade in Glioblastoma
by Mastrella, G and Hou, MZ and Li, M and Stoecklein, VM and Zdouc, N and Vomar, MNM and Miletic, H and Reinhard, S and Herold-Mende, CC and Kleber, S and Eisenhut, K and Gargiulo, G and Synowitz, M and Vescovi, AL and Harter, PN and Penninger, JM and Wagner, E and Mittelbronn, M and Bjerkvig, R and Hambardzumyan, D and Schuller, U and Tonn, JC and Radke, J and Glass, R and Kalin, RE
CANCER RESEARCH, ISSN 0008-5472, 05/2019, Volume 79, Issue 9, pp. 2298 - 2313
Antiangiogenic therapy of glioblastoma (GBM) with bevacizumab, a VEGFA-blocking antibody, may accelerate tumor cell invasion and induce alternative angiogenic... 
ENDOGENOUS LIGAND | ANGIOGENESIS | ONCOLOGY | BEVACIZUMAB | GLIOMA | HEART-FAILURE | APELIN | RECEPTOR | RADIOTHERAPY | TUMOR-GROWTH | TEMOZOLOMIDE
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Podoplanin expression is a prognostic biomarker but may be dispensable for the malignancy of glioblastoma
by Eisemann, Tanja and Costa, Barbara and Harter, Patrick N and Wick, Wolfgang and Mittelbronn, Michel and Angel, Peter and Peterziel, Heike
Neuro-Oncology, ISSN 1522-8517, 02/2019, Volume 21, Issue 3, pp. 326 - 336
Abstract Background Treatment options of glioblastoma, the most aggressive primary brain tumor with frequent relapses and high mortality, are still very... 
STEM-CELLS | PLATELET-AGGREGATION | MARKER | therapy | brain tumor | ANTIBODY | CANCER | CLINICAL NEUROLOGY | patient-derived xenografts | BRAIN-TUMORS | intracranial injection | ONCOLOGY | GLYCOPROTEIN
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Ceritinib-Induced Regression of an Insulin-Like Growth Factor-Driven Neuroepithelial Brain Tumor
by Russo, Alexandra and Paret, Claudia and Alt, Francesca and Burhenne, Jürgen and Fresnais, Margaux and Wagner, Wolfgang and Glaser, Martin and Bender, Hannah and Huprich, Sabrina and Harter, Patrick N and Filipski, Katharina and Lehmann, Nadine and Backes, Nora and Roth, Lea and Seidmann, Larissa and Sommer, Clemens and Brockmann, Marc A and Pietsch, Torsten and Neu, Marie A and Wingerter, Arthur and Faber, Jörg
International journal of molecular sciences, ISSN 1422-0067, 08/2019, Volume 20, Issue 17, p. 4267
The insulin-like growth factor (IGF) pathway plays an important role in several brain tumor entities. However, the lack of inhibitors crossing the blood-brain... 
IGF | SHH | NOTCH1 | ATO | WNT | ceritinib
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Therapeutic Targeting of Stat3 Using Lipopolyplex Nanoparticle-Formulated siRNA in a Syngeneic Orthotopic Mouse Glioma Model
by Linder, B and Weirauch, U and Ewe, A and Uhmann, A and Seifert, V and Mittelbronn, M and Harter, PN and Aigner, A and Kogel, D
CANCERS, ISSN 2072-6694, 03/2019, Volume 11, Issue 3, p. 333
Glioblastoma (GBM), WHO grade IV, is the most aggressive primary brain tumor in adults. The median survival time using standard therapy is only 12-15 months... 
RNA INTERFERENCE | STAT3 | TUMOR | polyethylenimine | DELIVERY | IN-VITRO | glioblastoma | INHIBITION | ONCOLOGY | PEI | GROWTH | siRNA delivery | siRNA/RNAi | glioma | lipopolyplex | LIPOSOME-POLYETHYLENIMINE COMPLEXES | EXPRESSION | SIGNAL TRANSDUCER
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Fitting algorithms and baseline correction influence the results of non‐invasive in vivo quantitation of 2‐hydroxyglutarate with 1H‐MRS
by Wenger, Katharina J and Hattingen, Elke and Harter, Patrick N and Richter, Christian and Franz, Kea and Steinbach, Joachim P and Bähr, Oliver and Pilatus, Ulrich
NMR in Biomedicine, ISSN 0952-3480, 01/2019, Volume 32, Issue 1, p. n/a
1H‐MRS enables non‐invasive detection of 2‐hydroxyglutarate (2‐HG), an oncometabolite accumulating in gliomas carrying mutations in the isocitrate... 
glioma | 2‐hydroxyglutarate | 1H‐MRS | post‐processing analysis | mutations in the IDH genes | Bias | Macromolecules | Clinical trials | Time domain analysis | Lipids | Data processing | Software reliability | Quantitation | Software development tools | Tissues | Algorithms | Magnetic resonance imaging | Outliers (statistics) | Biomarkers | Reliability analysis | Bioindicators | Mutation | Isocitrate dehydrogenase | Mercury | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Dabrafenib in patients with recurrent, BRAF V600E mutated malignant glioma and leptomeningeal disease
by Burger, Michael C and Ronellenfitsch, Michael W and Lorenz, Nadja I and Wagner, Marlies and Voss, Martin and Capper, David and Tzaridis, Theophilos and Herrlinger, Ulrich and Steinbach, Joachim P and Stoffels, Gabriele and Langen, Karl-Josef and Brandts, Christian and Senft, Christian and Harter, Patrick N and Bähr, Oliver
Oncology Reports, ISSN 1021-335X, 12/2017, Volume 38, Issue 6, pp. 3291 - 3296
BRAF V600E mutations occur frequently in malignant melanoma, but are rare in most malignant glioma subtypes. Besides, more benign brain tumors such as... 
BRAF V600E | leptomeningeal disease | glioblastoma | pleomorphic xanthoastrocytoma | PXA | glioma | BRAF | dabrafenib | Glioma | Glioblastoma | Dabrafenib | Leptomeningeal disease | Pleomorphic xanthoastrocytoma | IMPROVED SURVIVAL | LOW-GRADE GLIOMAS | ADJUVANT TEMOZOLOMIDE | INHIBITION | BRAF(V600E) MUTATION | ONCOLOGY | CENTRAL-NERVOUS-SYSTEM | STEM GANGLIOGLIOMA | VEMURAFENIB | Medical research | Care and treatment | Relapse | Chemotherapy | Gene mutations | Gliomas | Brain tumors | Melanoma | Medicine, Experimental | Diseases | Cancer | Development and progression | Genetic aspects | Health aspects | Pediatrics | Cell culture | Phosphorylation | Brain cancer | Radiation therapy | Patients | Skin cancer | Histopathology | Microscopy | Medical prognosis | DNA methylation | Mutation | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Angiopoietin-2 promotes myeloid cell infiltration in a β 2- integrin-dependent manner
by Scholz, Alexander and Lang, Victoria and Henschler, Reinhard and Czabanka, Marcus and Vajkoczy, Peter and Chavakis, Emmanouil and Drynski, Janina and Harter, Patrick N and Mittelbronn, Michel and Dumont, Daniel J and Plate, Karl H and Reiss, Yvonne
Blood, ISSN 0006-4971, 11/2011, Volume 118, Issue 18, pp. 5050 - 5059
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Disruption of peroxisome proliferator-activated receptor γ coactivator (PGC)-1α reverts key features of the neoplastic phenotype of glioma cells
by Bruns, Ines and Sauer, Benedikt and Burger, Michael C and Eriksson, Jule and Hofmann, Ute and Braun, Yannick and Harter, Patrick N and Luger, Anna-Luisa and Ronellenfitsch, Michael W and Steinbach, Joachim P and Rieger, Johannes
The Journal of biological chemistry, ISSN 0021-9258, 03/2019, Volume 294, Issue 9, pp. 3037 - 3050
The peroxisome proliferator-activated receptor γ coactivator (PGC)-1α is a master regulator of mitochondrial biogenesis and controls metabolism by coordinating... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Doxycycline impairs mitochondrial function and protects human glioma cells from hypoxia-induced cell death: Implications of using tet-inducible systems
by Luger, Anna-Luisa and Sauer, Benedikt and Lorenz, Nadja I and Engel, Anna L and Braun, Yannick and Voss, Martin and Harter, Patrick N and Steinbach, Joachim P and Ronellenfitsch, Michael W
International Journal of Molecular Sciences, ISSN 1661-6596, 05/2018, Volume 19, Issue 5, p. 1504
Inducible gene expression is an important tool in molecular biology research to study protein function. Most frequently, the antibiotic doxycycline is used for... 
Mitochondria | Tumor metabolism | Doxycycline | Glioblastoma | Hypoxia-induced cell death | Tet-inducible system | Inducible gene expression | Tetracycline | MAMMALIAN TARGET | inducible gene expression | STEM-CELLS | ACTIVATION | mitochondria | BIOCHEMISTRY & MOLECULAR BIOLOGY | doxycycline | CHEMISTRY, MULTIDISCIPLINARY | hypoxia-induced cell death | MALIGNANT GLIOMA | glioblastoma | INHIBITION | RIBOSOMES | tetracycline | BINDING | EXPRESSION | tumor metabolism
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Disruption of peroxisome proliferator–activated receptor coactivator (PGC)-1 reverts key features of the neoplastic phenotype of glioma cells
by Bruns, Ines and Sauer, Benedikt and Burger, Michael C and Eriksson, Jule and Hofmann, Ute and Braun, Yannick and Harter, Patrick N and Luger, Anna-Luisa and Ronellenfitsch, Michael W and Steinbach, Joachim P and Rieger, Johannes
Journal of Biological Chemistry, ISSN 0021-9258, 2019, Volume 294, Issue 9, pp. 3037 - 3050
The peroxisome proliferator-activated receptor coactivator (PGC)-1 is a master regulator of mitochondrial biogenesis and controls metabolism by coordinating... 
MAMMALIAN TARGET | CANCER-CELLS | hypoxia | MITOCHONDRIAL BIOGENESIS | VEGF | BIOCHEMISTRY & MOLECULAR BIOLOGY | reactive oxygen species (ROS) | GLUCOSE TRANSPORTERS | glioblastoma | PROTECTS GLIOMA | METABOLISM | peroxisome proliferator-activated receptor coactivator 1-(PGC-1) (PPARGC1A) | RESPIRATION | transcription coactivator | EXPRESSION | tumor metabolism | GAMMA COACTIVATOR-1
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text Chordoid meningiomas can be sub-stratified into prognostically distinct DNA methylation classes and are enriched for heterozygous deletions of chromosomal arm 2p
by Sievers, Philipp and Stichel, Damian and Hielscher, Thomas and Schrimpf, Daniel and Reinhardt, Annekathrin and Wefers, Annika K and Reuss, David and Jones, David T. W and Bewerunge-Hudler, Melanie and Hartmann, Christian and Baumgarten, Peter and Wirsching, Hans-Georg and Winther-Kristensen, Bjarne and Brokinkel, Benjamin and Ketter, Ralf and Idoate Gastearena, Miguel Angel and Lamszus, Katrin and Seiz-Rosenhagen, Marcel and Mawrin, Christian and Harter, Patrick N and Felsberg, Jörg and Hänggi, Daniel and Herold-Mende, Christel and Berghoff, Anna Sophie and Weller, Michael and Pfister, Stefan M and Wick, Wolfgang and Reifenberger, Guido and Preusser, Matthias and von Deimling, Andreas and Sahm, Felix
Acta Neuropathologica, ISSN 0001-6322, 12/2018, Volume 136, Issue 6, pp. 975 - 978
Medicine & Public Health | Pathology | Neurosciences | SYSTEM | TRAF7 | CLASSIFICATION | AKT1 | MUTATIONS | PATHOLOGY | KLF4 | TUMORS | NEUROSCIENCES | CLINICAL NEUROLOGY | DNA methylation | Methylation
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
18. Full Text MYCN amplification drives an aggressive form of spinal ependymoma
by Ghasemi, David R and Sill, Martin and Okonechnikov, Konstantin and Korshunov, Andrey and Yip, Stephen and Schutz, Peter W and Scheie, David and Kruse, Anders and Harter, Patrick N and Kastelan, Marina and Wagner, Marlies and Hartmann, Christian and Benzel, Julia and Maass, Kendra K and Khasraw, Mustafa and Sträter, Ronald and Thomas, Christian and Paulus, Werner and Kratz, Christian P and Witt, Hendrik and Kawauchi, Daisuke and Herold-Mende, Christel and Sahm, Felix and Brandner, Sebastian and Kool, Marcel and Jones, David T W and von Deimling, Andreas and Pfister, Stefan M and Reuss, David E and Pajtler, Kristian W
Acta neuropathologica, ISSN 0001-6322, 08/2019
Spinal ependymal tumors form a histologically and molecularly heterogeneous group of tumors with generally good prognosis. However, their treatment can be... 
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights